| Lot Release Number |
2019-06-19-0130
|
| FDA Registered Product/Generic Name |
Diphtheria, Tetanus, Pertussis (Acellular Component), and Poliomyelitis (Inactivated) Vaccine (Adsorbed)
|
| Brand Name |
Tetraxim
|
| Dosage Strength |
-
|
| Dosage Form |
Suspension for Injection (I.M.)
|
| Registration Number |
BR-518
|
| Batch/Lot Number |
R3A22
|
| Packaging Lot |
Packaging Lot: Box - R3A221V, MD: 11012018, ED: 12-2020; PFS - R3A22, MD: 11012018, ED: 12-2020; Needle: 25G x5/8" (0.5 x 16mm) - 1902020, ED: 2024-01-31; Needle 23G x 1" (0.6 x 25mm) - 1901042, ED: 2023-12-31
|
| Product Expiration Date |
31 December 2020
|
| Issuance Date |
28 June 2019
|